X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
k-877 (22) 22
index medicus (15) 15
pemafibrate (13) 13
humans (12) 12
triglycerides (11) 11
benzoxazoles - therapeutic use (9) 9
butyrates - therapeutic use (9) 9
male (9) 9
cholesterol (8) 8
double-blind (8) 8
dyslipidemia (8) 8
spparm-alpha (8) 8
diabetes (7) 7
female (7) 7
pharmacology & pharmacy (7) 7
type-2 diabetes-mellitus (7) 7
cardiac & cardiovascular systems (6) 6
dyslipidemias - drug therapy (6) 6
fenofibrate (6) 6
middle aged (6) 6
ppar alpha - agonists (6) 6
animals (5) 5
atherosclerosis (5) 5
benzoxazoles - adverse effects (5) 5
butyrates - adverse effects (5) 5
cardiovascular (5) 5
endocrinology & metabolism (5) 5
hypolipidemic agents - therapeutic use (5) 5
lipids (5) 5
peripheral vascular disease (5) 5
ppar alpha - metabolism (5) 5
risk (5) 5
safety (5) 5
atherogenic dyslipidemia (4) 4
benzoxazoles - pharmacology (4) 4
butyrates - pharmacology (4) 4
cardiovascular-disease (4) 4
fibrate (4) 4
liver (4) 4
metabolism (4) 4
ppar-alpha modulator (4) 4
remnant cholesterol (4) 4
residual cardiovascular risk (4) 4
spparmα (4) 4
treatment outcome (4) 4
triglyceride (4) 4
adult (3) 3
aged (3) 3
biomarkers - blood (3) 3
cardiology and cardiovascular medicine (3) 3
cardiovascular diseases (3) 3
coronary-artery-disease (3) 3
coronary-heart-disease (3) 3
density-lipoprotein cholesterol (3) 3
disease (3) 3
double-blind method (3) 3
dyslipidaemia (3) 3
fenofibrate therapy (3) 3
hypertriglyceridemia - drug therapy (3) 3
hypertriglyceridemia - metabolism (3) 3
insulin (3) 3
insulin resistance (3) 3
lipids - blood (3) 3
lipoproteins (3) 3
metaanalysis (3) 3
metabolic syndrome (3) 3
original (3) 3
patients (3) 3
renal dysfunction (3) 3
review (3) 3
selective peroxisome proliferator-activated receptor alpha modulator (3) 3
selective pparα modulator (3) 3
spparm (3) 3
spparm alpha (3) 3
statins (3) 3
term fenofibrate therapy (3) 3
type 2 diabetes (3) 3
apolipoprotein-b (2) 2
arteriosclerosis (2) 2
association (2) 2
benzoxazoles - administration & dosage (2) 2
blood cholesterol (2) 2
butyrates - administration & dosage (2) 2
cardiovascular disease (2) 2
cardiovascular outcomes (2) 2
chylomicron remnants (2) 2
clinical trials (2) 2
combination (2) 2
complications and side effects (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
diet, high-fat - adverse effects (2) 2
drugs (2) 2
dyslipidemias - blood (2) 2
dyslipidemias - diagnosis (2) 2
dyslipidemias - metabolism (2) 2
fenofibrate - therapeutic use (2) 2
fibrates (2) 2
glucose - metabolism (2) 2
heart-disease (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Atherosclerosis and Thrombosis, ISSN 1340-3478, 2017
Aims: Fasting and postprandial hypertriglyceridemia (PHTG) are caused by the accumulation of triglyceride (TG)-rich lipoproteins and their remnants, which have... 
Fenofibrate | SPPARMα | Chylomicron remnants | K-877 (Pemafibrate) | Postprandial hypertriglyceridemia
Journal Article
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 02/2019, Volume 20, Issue 3
Pemafibrate (K-877) is a novel selective peroxisome proliferator-activated receptor- modulator (SPPARM) with a favorable benefit-risk balance. Previous... 
K-877 | triglyceride | PPAR-ALPHA MODULATOR | MANAGEMENT | FENOFIBRATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | pemafibrate | renal dysfunction | HYPERTRIGLYCERIDEMIA | CHEMISTRY, MULTIDISCIPLINARY | 2016 ESC/EAS GUIDELINES | selective PPAR modulator | PHARMACOKINETICS | safety | high-density lipoprotein cholesterol | DOUBLE-BLIND | KIDNEY | BEZAFIBRATE
Journal Article
Atherosclerosis, ISSN 0021-9150, 2017, Volume 261, pp. 144 - 152
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 11/2018, Volume 838, pp. 78 - 84
Journal Article
Cardiovascular Diabetology, 06/2019, Volume 18, Issue 1, pp. 1 - 20
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 03/2019, Volume 18, Issue 1, pp. 38 - 38